期刊
MYCOSES
卷 58, 期 5, 页码 303-307出版社
WILEY
DOI: 10.1111/myc.12315
关键词
Dermatophytosis; Trichophyton species; E; floccosum; ITS rDNA; antifungal susceptibility
资金
- School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
- Basilea Pharmaceutica Ltd, Basel, Switzerland
Despite the common, worldwide, occurrence of dermatophytes, little information is available regarding susceptibility profiles against currently available and novel antifungal agents. A collection of sixty-eight clinical Trichophyton species and Epidermophyton floccosum were previously identified and verified to the species level by sequencing the internal transcribed spacer (ITS) regions of rDNA. MICs of amphotericin B, fluconazole, itraconazole, voriconazole, posaconazole, isavuconazole, terbinafine and MECs of caspofungin and anidulafungin were performed based on CLSI M38-A2. The resulting MIC(90)s of all strains were, in increasing order, as follows: terbinafine (0.063mgl(-1)); posaconazole (1mgl(-1)); isavuconazole and anidulafungin (2mgl(-1)); itraconazole, voriconazole, amphotericin B, and caspofungin (4mgl(-1)) and fluconazole (>64mgl(-1)). These results confirm that terbinafine is an excellent agent for treatment of dermatophytosis due to T. rubrum, T. mentagrophytes, T. verrucosum, T. schoenleinii and E. floccosum. In addition, the new azoles POS and ISA are potentially useful antifungals to treat dermatophytosis. However, the clinical effectiveness of these novel antifungals remains to be determined.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据